MarginsXMarginsX
Home › Markets › Health Care › IMCC

IM Cannabis Corp. Common Shares (IMCC)

IMCC trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4950
-12.76% on the day
Market cap
$913K
Nano cap
Revenue · 2025
$38.4M
+1.3% on 2024
Net income · 2025
-$7.9M
-20.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/0001178913-26-001877-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerIMCC on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001792030
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inBC

Financials · 2025

LineValue
Revenue$38.4M
Net income-$7.9M
Operating income-$8.1M
Net margin-20.7%
Operating margin-21.2%
Revenue growth+1.3%
Cash$1.9M
Total assets$22.3M
P/E (computed)Net income was not positive
P/S (computed)0.0×

Reported in CAD; shown in US dollars.

Warning signs

Cash runway
Cash-flow positive
2.7M CAD cash at December 31, 2025
Share count, 1 year
+91.1%
2024-12-31 to 2025-12-31 · +367.3% over 3 years
Going-concern doubt
Yes
20-F filed March 30, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about our ability to continue as a going concern."
20-F 2026-03-30
Cash and burn2.7M CAD cash; operating cash flow 1.2M CAD a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2025-12-31
Reverse splits, 3 years2; latest 1-for-30 on 2026-08-27Source 2026-08-27
Shelf and offerings, 12 months4 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-09-24
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorFahn Kanne & Co., Tel-Aviv, IsraelPCAOB Form AP 2026-04-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
54.7M CAD-11.3M CAD4.7M CAD2.7M CAD15.3M CAD54.7M CAD20-F 2026-03-30
FY 2024
2024-12-31
54.0M CAD-10.6M CAD-1.1M CAD863K CAD15.6M CAD54.0M CAD20-F 2026-03-30
FY 2023
2023-12-31
48.8M CAD-9.5M CAD-8.1M CAD1.8M CAD12.5M CAD48.8M CAD20-F 2026-03-30
FY 2022
2022-12-31
54.3M CAD-188.9M CAD-12.6M CAD2.4M CAD9.6M CAD54.3M CAD20-F 2025-03-31
FY 2021
2021-12-31
34.1M CAD-17.8M CAD-34.4M CAD13.9M CAD9.9M CAD34.1M CAD20-F 2024-03-28
FY 2020
2020-12-31
15.9M CAD-28.7M CAD-7.9M CAD8.9M CAD0 CAD15.9M CAD20-F 2023-03-29
FY 2019
2019-12-31
9.1M CAD-7.3M CAD-6.0M CAD13.9M CADNo debt tags9.1M CAD40-F/A 2021-05-19

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentF-32026-11-10
Latest annual report20-F2026-03-30
Latest quarterly / interim6-K2026-11-13

Source: SEC EDGAR submissions feed, 307 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.0%
1 month-58.2%
3 months-85.4%
Year to date-98.6%
1 year-98.6%
From 52-week high-99.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
XXII22nd Century Group Inc.$0.4932-35.96%$272K
AKANAkanda Corp. Common Shares$2.21+62.50%$5.3M
NAIINatural Alternatives International Inc.$0.9700+0.35%$6.1M
MTEXMannatech Incorporated$3.76-40.32%$7.3M
BONBon Natural Life Limited$1.09-0.91%$8.9M
BTMDBiote Corp.$0.9603-9.83%$34.5M
FTLFFitLife Brands Inc.$6.83-19.46%$64.1M
ISPRIspire Technology Inc.$1.52-10.06%$87.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier